Lateral hypothalamic neurotensin neurons and narcolepsy symptoms

Who could benefit from this research

What this research studies

This project studies how neurotensin-producing neurons in the lateral hypothalamus influence narcolepsy with cataplexy. By monitoring these neurons during wakefulness, sleep loss, and exposure to emotional cues in both normal and narcolepsy-model mice, it tests whether increasing NtsLH activity lessens symptoms. The work uses cellular and population-level recordings to understand activity patterns and causal relationships with sleepiness and muscle weakness. If NtsLH signaling helps mitigate NT1 symptoms, it could point to new avenues for therapies that compensate for orexin loss.

Why it matters

Where this research is happening

• Beth Israel Deaconess Medical Center
  Boston, United States Active

Researchers

• Principal investigator: Ramalingam, Vetrivelan — Beth Israel Deaconess Medical Center
• Study coordinator: Ramalingam, Vetrivelan

Related research

Other NIH-funded projects on the same topics.

• Using genetics to reduce misdiagnosis of narcolepsy and sleep-wake rhythm disorders

  Researchers will create genetic risk scores that work across ancestries to help people with suspected narcolepsy and circadian rhythm sleep-wake disorders get diagnosed more accurately.

  NIH research Brigham and Women's Hospital · Boston, United States · NIH-11261119

• Using genetics to improve diagnosis of narcolepsy and sleep disorders.

  This study is working to make it easier and faster for people with narcolepsy and sleep-wake disorders to get the right diagnosis by using genetic tests that are affordable and can help everyone, no matter their background.

  NIH research Brigham and Women's Hospital · Boston, United States · NIH-11051238

• Understanding the brain mechanisms behind narcolepsy and cataplexy

  This study is looking at how certain parts of the brain and chemicals in our body affect sleep and sudden muscle weakness in people with narcolepsy, hoping to find out more about what causes these issues so we can better understand and help those who experience them.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11035074

• HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults

  This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.

  Recruiting at 29 sites Phase 3 Harmony Biosciences Management, Inc. · Birmingham, Alabama and 52 other locations · NCT07675135

• Expanded-dosing Xywav vs placebo in narcolepsy and IH

  This study tests whether expanded nightly dosing of Xywav helps adults with narcolepsy or idiopathic hypersomnia, compared with placebo.

  Recruiting at 15 sites Phase 3 Jazz Pharmaceuticals · Birmingham, Alabama and 14 other locations · NCT07625280

• Testing Lu AH69593 for safety and tolerance in healthy adults and people with narcolepsy

  This study tests whether Lu AH69593 is safe and well tolerated in adults, including those with narcolepsy, and looks at how the body processes the drug with and without food.

  Recruiting Phase 1 H. Lundbeck A/S · Helsinki and 1 other locations · NCT07613710

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.